alovudine has been researched along with HIV Coinfection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, HK; Buckheit, KW; Buckheit, RW; Parang, K | 1 |
| Balzarini, J; Hamon, N; McGuigan, C; Velanguparackel, W; Westwell, AD | 1 |
| Agarwal, HK; Chhikara, BS; Doncel, GF; Parang, K | 1 |
| Figlerowicz, M; Hamy, F; Klimkait, T; Kulikowski, T; Kurzyńska-Kokorniak, A; Louvel, S; Miazga, A; Pietrusiewicz, Z; Wińska, P | 1 |
| Rusconi, S | 1 |
| Otto, MJ | 1 |
| Calvez, V; Ghosn, J; Harmenberg, J; Katlama, C; Mårdh, G; Oberg, B; Tubiana, R; Valantin, MA; Wirden, M | 1 |
| Bravo, ML; Cotte, L; Dorléacq, N; Ghosn, J; Harmenberg, J; Katlama, C; Mårdh, G; Mayers, D; Piketty, C; Quinson, AM; Sabo, N; Valdez, H | 1 |
| Albert, J; Cox, SW; Ljungdahl-Ståhle, E; Wahren, B | 1 |
| Armstrong, D; Barditch-Crovo, PA; Baron, PA; Duncanson, F; Flexner, C; Ganes, D; Jacobson, MA; Petty, BG; Powderly, W; van der Horst, C | 1 |
| Mankertz, J; Matthes, E; Pauli, G; Riedel, E; Rokos, K; von Baeyer, H | 1 |
| Kim, EY; Merigan, TC; Oberg, B; Vrang, L | 1 |
2 review(s) available for alovudine and HIV Coinfection
| Article | Year |
|---|---|
Alovudine Medivir.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contraindications; Dideoxynucleosides; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2003 |
New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Cytidine Triphosphate; Deoxycytidine; Dideoxynucleosides; Dioxolanes; Emtricitabine; HIV Infections; Humans; Purine Nucleosides; Reverse Transcriptase Inhibitors; Thionucleosides; Zalcitabine | 2004 |
3 trial(s) available for alovudine and HIV Coinfection
| Article | Year |
|---|---|
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Middle Aged; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Failure; Viral Load | 2004 |
Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Female; HIV; HIV Infections; Humans; Male; Middle Aged; RNA, Viral; Viral Load | 2007 |
Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials.
Topics: Adult; Aged; Antiviral Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; HIV; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Prospective Studies | 1994 |
7 other study(ies) available for alovudine and HIV Coinfection
| Article | Year |
|---|---|
Synthesis and anti-HIV activities of symmetrical dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line; Dicarboxylic Acids; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2012 |
Synthesis, anti-HIV and cytostatic evaluation of 3'-deoxy-3'-fluorothymidine (FLT) pro-nucleotides.
Topics: Anti-HIV Agents; Cytostatic Agents; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Nucleotides | 2014 |
Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Dicarboxylic Acids; Esters; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Reverse Transcriptase Inhibitors | 2017 |
Thiated derivatives of 2',3'-dideoxy-3'-fluorothymidine: synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms.
Topics: Anti-HIV Agents; Cell Line; Dideoxynucleosides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Reverse Transcriptase Inhibitors | 2011 |
Effect of resistance on combination chemotherapy for human immunodeficiency virus infection.
Topics: Antiviral Agents; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1993 |
Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells.
Topics: Cells, Cultured; Dideoxynucleosides; Endocytosis; HIV Infections; HIV Reverse Transcriptase; Humans; Leukocytes, Mononuclear; Lipoproteins, LDL; Receptors, LDL; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1996 |
Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.
Topics: Clone Cells; Dideoxynucleosides; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 2001 |